From Phase I and Beyond

Integrating your sterile fill-finish journey

Over the last five years the Clinical Trial market has experienced a rapid transformation towards Biologic and Injectable therapies. With applications for biotech patents increasing 25% year on year.

Due to their complexity and characteristics, there are many challenges associated with the development, manufacturing and distribution of injectable products. Reducing this complexity with a fully integrated and trusted supply chain is vital to success.

Join PCI Pharma Services and our partners, Aptar Pharma and Cytiva as we explore these challenges and offer proactive solutions to ensure a secure supply chain from Phase I and Beyond, ensuring a safe and uninterrupted supply of lifechanging therapies to patients worldwide.


Be sure to stay for our social networking event! We hope to see you there!

Register Below:

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are local and global